Current through Vol. 42, No. 1, September 16, 2024
(a) Commercial
feed, other than customer-formula feed, shall be labeled with the information
prescribed in this subchapter and in the following general format.
(1) Product name and brand name, if any, as
stipulated in
35:30-27-3(a)(1).
(2) If a drug is used, label as stipulated in
35:30-27-3(a)(2).
(3) Purpose Statement as stipulated in
35:30-27-3(a)(3).
(4) Guaranteed analysis as stipulated in
35:30-27-3(a)(4).
(5) Feed ingredients as stipulated in
35:30-27-3(5).
(6) Name and principal mailing address of the
manufacturer or person responsible for distributing the feed as stipulated in
35:30-27-3(a)(7).
(7) Directions for use and precautionary
statements as stipulated in
35:30-27-3(6).
(8) Net weight or mass net volume or count
and metric equivalent.
(b) The presentation of information and the
label format shall meet the requirements of applicable State and Federal
packaging regulations. "Uniform Packaging and Labeling Regulation" as adopted
by the National Conference on Weights and Measures and published in the
National Institute of Standards and Technology (NIST) Handbook 130 and
amendments.
(1) The information required
within 35:30-27-2(a)(1) -(5) and (7)-(8) shall appear entirely on one side of
the label or on one side of the container.
(2) Additional information besides that
required within 35:30-27-2 may be placed on a supplemental label.
(c) Customer-formula feed shall be
accompanied with the information prescribed in this subchapter using labels,
invoices, delivery tickets, or other shipping documents bearing the following
information:
(1) The name and address of the
manufacturer.
(2) The name and
address of the purchaser.
(3) The
date of sale or delivery.
(4) The
customer-formula feed name and brand name, if any.
(5) The product name and net weight of each
commercial feed and each other ingredient used in the mixture; except when
approved by the Board, the manufacturer may affix the statement
"Customer-formula on file" in lieu of ingredient list. This formula shall be
made available to the feed purchaser upon request.
(6) The directions for use and precautionary
statements as required by
35:30-27-6
and
35:30-27-7.
(7) If a drug containing product is used:
(A) The purpose of the medication (claim
statement).
(B) The established
name of each active drug ingredient and the level of each drug used in the
final mixture expressed in accordance with
35:30-27-4(d).
Amended at 13 Ok Reg
2339, eff 6-28-96; Amended at 17 Ok Reg 2842, eff
7-13-00
